What is PRISMAP?

Brief video introduction of the project

watch on

share on

How to apply?

Brief video introduction of the project

watch on

share on

Our facilities and services

What can our facilities do for you?

watch on

share on

Project description

Our main goal is to provide a sustainable source of high purity grade new radionuclides for medicine, involving from the onset upcoming major European infrastructures, to provide a single-entry point for all researchers active in this field including SMEs, global pharma, nuclear centres, hospitals and universities, using standardised access procedures. The new isotope enrichment and standardisation techniques triggered in PRISMAP will expand our services and provide them to yet unreachable remote European laboratories. PRISMAP thus strives to create a paradigm shift in the early phase research on radiopharmaceuticals, targeted drugs for cancer – one of the major diseases in Europe – theranostics and personalised medicine, shaping the European isotope landmark as a gold standard to accelerate the development of the pharma industry and ultimately of a better healthcare for the improvement of our citizens’ life.

Our objectives are:

  • Provide access to new radionuclides and new purity grades for the medical research
  • Create a common entry port and web interface to the starting research community
  • Enhance clarity and regulatory procedures to enhance research with radiopharmaceuticals
  • Improve the delivered radionuclide data and regulation, along with biomedical research capacity
  • Ensure sustainability of PRISMAP on the long term

Notably, PRISMAP addresses cancer which is a major societal challenge as recently reconfirmed by Europe's Beating Cancer Plan.

Workplan

The PRISMAP work plan consists of 13 work packages, including 3 transnational access activities, 5 networking activities, 4 enabling research activities and a work package dedicated to the project’s management.

The transnational access activities comprise the creation of the web-based entry platform, the coordination of the user selection and access procedures, the production and dispatch of non-conventional radionuclides. They also provide access to translational research for medical applications.

The networking activities are focussed on harmonisation and standardisation of non-conventional radionuclides, fostering industrial and clinical collaboration and making available multidisciplinary training and education. They also promote the dissemination, communication, and sustainability of PRISMAP results, and the involvement of emerging infrastructures.

Enabling research activities, concentrate on transport and shipping of the novel radionuclides within the network, the optimisation of ion sources, targets and enrichment techniques for medical radionuclide production, the data generation for translational research, and the development of radiolanthanides for use in clinical settings.

Schematic view of the PRISMAP work packages, which include transnational access activities,
networking activities and joint research activities.